Compare
Precipio, Inc. vs EyePoint, Inc. vs Rapid Micro Biosystems, Inc. vs Seer, Inc.
| Latest fiscal year | Precipio, Inc. PRPO | EyePoint, Inc. EYPT | Rapid Micro Biosystems, Inc. RPID | Seer, Inc. SEER |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $24.05M | $31.37M | $33.59M | $16.58M |
| Revenue growth (YoY) | +29.8% | -27.5% | +19.7% | +17.0% |
| Gross margin | 44.5% | n/a | n/a | 51.1% |
| Operating margin | -5.0% | -776.0% | -141.1% | -470.5% |
| Net margin | -1.5% | -739.4% | -140.3% | -444.0% |
| Net income | -$363.0K | -$231.96M | -$47.12M | -$73.60M |
| EPS (Diluted) | -$0.23 | -$3.17 | -$1.05 | n/a |
| Operating cash flow | $685.0K | -$240.11M | -$31.06M | -$44.45M |
| Free cash flow | $359.0K | -$243.39M | -$31.91M | -$46.24M |
| Cash & equivalents | $2.65M | $101.82M | $20.03M | $47.28M |
| Total assets | $21.32M | $364.00M | $74.85M | $296.08M |
| Total liabilities | $6.76M | $57.88M | $41.65M | $36.78M |
| Shareholders' equity | $14.56M | $306.11M | $33.21M | $259.31M |
| Return on year-end equity | -2.5% | -75.8% | -141.9% | -28.4% |
| Shares outstanding | 1.78M | 82.83M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Precipio, Inc. | EyePoint, Inc. | Rapid Micro Biosystems, Inc. | Seer, Inc. |
|---|---|---|---|---|
| Latest | $24.05M Ended 2025-12-31 | $31.37M Ended 2025-12-31 | $33.59M Ended 2025-12-31 | $16.58M Ended 2025-12-31 |
| 1 year earlier | $18.53M Ended 2024-12-31 | $43.27M Ended 2024-12-31 | $28.05M Ended 2024-12-31 | $14.17M Ended 2024-12-31 |
| 2 years earlier | $15.20M Ended 2023-12-31 | $46.02M Ended 2023-12-31 | $22.52M Ended 2023-12-31 | $16.66M Ended 2023-12-31 |
| 3 years earlier | $9.41M Ended 2022-12-31 | $41.40M Ended 2022-12-31 | $17.13M Ended 2022-12-31 | $15.49M Ended 2022-12-31 |
| 4 years earlier | $8.85M Ended 2021-12-31 | $36.94M Ended 2021-12-31 | $23.23M Ended 2021-12-31 | $6.62M Ended 2021-12-31 |